Tech Souls, Connected.

DMart Reports 16.3% Revenue Rise but EBITDA Margin Dips to 7.94%

DMart Q1 FY26: Profit Flat at ₹773 Cr as Costs Rise Amid Robust Sales

Tough Competition and Higher Expenses Offset Revenue Gains

Financial Highlights

Avenue Supermarts, which operates the DMart chain, reported a nearly flat net profit of ₹773 crore for Q1 FY26, down just 0.1% from ₹774 crore a year earlier.

  • Revenue growth: Up 16.3% to ₹16,359.7 crore, from ₹14,069 crore in Q1 FY25.
  • Standalone performance: Net profit rose 2.1% to ₹830 crore, on revenues of ₹15,966.3 crore (versus ₹13,763.8 crore).

EBITDA and Margins Under Pressure

Consolidated EBITDA climbed 6.4% to ₹1,299 crore, compared with ₹1,221.2 crore in Q1 FY25.

  • EBITDA margin: Slipped to 7.94% from 8.68%, reflecting higher operating costs.

Competitive Intensity Weighs on Margins

Deflation in staples and non-food categories trimmed revenue impact by 100–150 bps,” said CEO Neville Noronha.

  • Gross margins fell due to intense FMCG competition.
  • Operating costs rose on service-level enhancements, capacity building, and wage inflation.

Rising staff costs mirror sector-wide pressures:

  • Quick commerce wages rose 17% over three years, from ₹25,600 (CY22) to ₹27,726 (CY24).
  • Retail chains like Vishal Mart face staff shortages amid expansion.

Employee Expenses and Store Expansion

Q1 saw a 30.3% jump in employee benefits, to ₹346.9 crore.

  • New stores: Added 9 outlets, taking the total to 424 as of June 30, 2025.
  • Planned openings: Another 10–12 stores expected in H2 FY26.

Same-Store Sales and Operational Metrics

Like-for-like sales growth slowed to 7.1%, down from 9.1% in Q1 FY25.

  • Sales per sq ft: Climbed sequentially to ₹8,779, still below the Q3 peak of ₹9,317.

Market Reaction

The stock fell 2.51% to ₹4,064.20 on the NSE on July 11, reflecting profit-booking and margin concerns.

“We remain confident in our model,” Noronha added, emphasising discipline in cost control and selective expansion.

Share this article
Shareable URL
Prev Post

Dr Agarwals Health Care Sees Block Deal Uptick as BOFA Takes 0.09% Stake

Next Post

How Markets Are Turning Trump’s Tariffs Into Growth Opportunities

Read next